Abstract
Conventional treatment of moderate-severe ulcerative colitis (UC) has resulted in only a limited therapeutic benefit. Advancing knowledge of UC pathogenesis and recent advances in biotechnology have led to the development of biological agents that selectively target individual inflammatory pathways. In particular, the role of tumor necrosis factor alpha (TNF-α) in UC pathogenesis has been clarified by serological and immunohistochemical studies in humans and by experimental models. Clinical efficacy of anti-TNF-α therapy with infliximab has been assessed in two large controlled trials, showing a good compromise between therapeutic gain and safety. The aim of this review is to provide an insight into the role of TNF-α and anti-TNF-α therapy in patients with UC and diverticular disease associated colitis.
Keywords: Biological therapy, ulcerative colitis, diverticular disease associated colitis
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title: Tumor Necrosis Factor Alpha in Ulcerative Colitis and Diverticular Disease Associated Colitis
Volume: 7 Issue: 3
Author(s): C. Hassan, A. Zullo, V. De Francesco, S. M.A. Campo, S. Morini, C. Panella and E. Ierardi
Affiliation:
Keywords: Biological therapy, ulcerative colitis, diverticular disease associated colitis
Abstract: Conventional treatment of moderate-severe ulcerative colitis (UC) has resulted in only a limited therapeutic benefit. Advancing knowledge of UC pathogenesis and recent advances in biotechnology have led to the development of biological agents that selectively target individual inflammatory pathways. In particular, the role of tumor necrosis factor alpha (TNF-α) in UC pathogenesis has been clarified by serological and immunohistochemical studies in humans and by experimental models. Clinical efficacy of anti-TNF-α therapy with infliximab has been assessed in two large controlled trials, showing a good compromise between therapeutic gain and safety. The aim of this review is to provide an insight into the role of TNF-α and anti-TNF-α therapy in patients with UC and diverticular disease associated colitis.
Export Options
About this article
Cite this article as:
Hassan C., Zullo A., De Francesco V., Campo M.A. S., Morini S., Panella C. and Ierardi E., Tumor Necrosis Factor Alpha in Ulcerative Colitis and Diverticular Disease Associated Colitis, Endocrine, Metabolic & Immune Disorders - Drug Targets 2007; 7 (3) . https://dx.doi.org/10.2174/187153007781662530
DOI https://dx.doi.org/10.2174/187153007781662530 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inhibition of Transcription Factors by Plant-Derived Compounds and their Implications in Inflammation and Cancer
Current Pharmaceutical Design Recent Insights into COVID-19 in Children and Clinical Recommendations
Current Pediatric Reviews Meet Our Editorial Board Member
Letters in Drug Design & Discovery Traditional Fruits of Kerala: Bioactive Compounds and their Curative Potential in Chronic Diseases
Current Nutrition & Food Science Proteomic Analysis of the Molecular Mechanisms of Chlorpromazine Inhibiting Migration of Oral Squamous Cell Carcinoma
Current Proteomics Sol-Gel Chemistry in Biosensing Devices of Electrical Transduction: Application to CEA Cancer Biomarker
Current Topics in Medicinal Chemistry A Comprehensive Study on Aptasensors For Cancer Diagnosis
Current Pharmaceutical Biotechnology The Use of Intravenous Aminobisphosphonates for the Treatment of Pagets Disease of Bone
Mini-Reviews in Medicinal Chemistry Investigation of In Vitro Antioxidant Activity and In Vivo Antipyretic and Anti-Inflammatory Activities of Algerian Eryngium campestre L.
Current Bioactive Compounds Metabolomics of Medicinal Plants: The Importance of Multivariate Analysis of Analytical Chemistry Data
Current Computer-Aided Drug Design Magnetic Resonance Imaging of Uncommon Hepatic Mesenchymal Tumours: Haemangioendothelioma and Angiosarcoma
Current Medical Imaging Synthesis and Biological Evaluation of 2-methoxy-N-phenyl-6-(5-phenyl-1, 3,4-oxadiazol-2-yl) pyridin-3-amine Derivatives as Antimicrobial Agents
Letters in Organic Chemistry Lanthenide-Doped Nanophosphor labels for Protein Microarrays
Current Pharmacogenomics and Personalized Medicine Investigation Binding Patterns of Human Carboxylesterase I (hCES I) with Broad Substrates by MD Simulations
Current Topics in Medicinal Chemistry Lung Cancer Detection from CT Images: Modified Adaptive Threshold Segmentation with Support Vector Machines and Artificial Neural Network Classifier
Current Medical Imaging Current Advances in the Synthesis and Antitumoral Activity of SIRT1-2 Inhibitors by Modulation of p53 and Pro-Apoptotic Proteins
Current Medicinal Chemistry Recent Developments and Patents on Biological Sensing using Nanoparticles in Microfluidic Systems
Recent Patents on Nanotechnology Synthesis and Anticonvulsant Activity of Some Non-Classical Dihydropyridine Like Structures
Letters in Drug Design & Discovery MMP7 Induces T-DM1 Resistance and Leads to the Poor Prognosis of Gastric Adenocarcinoma via a DKK1-Dependent Manner
Anti-Cancer Agents in Medicinal Chemistry Bioactivity of Chitosan and Its Derivatives
Current Organic Chemistry